VC
Vivo Capital’s Tarsus Pharmaceuticals TARS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-565,550
| Closed | -$15.4M | – | 44 |
|
|
2024
Q2 | $15.4M | Hold |
565,550
| – | – | 1.42% | 16 |
|
|
2024
Q1 | $20.6M | Sell |
565,550
-1,218,456
| -68% | -$44.3M | 1.62% | 16 |
|
|
2023
Q4 | $36.1M | Sell |
1,784,006
-478,194
| -21% | -$9.68M | 2.96% | 10 |
|
|
2023
Q3 | $40.2M | Hold |
2,262,200
| – | – | 4.4% | 6 |
|
|
2023
Q2 | $40.9M | Hold |
2,262,200
| – | – | 2.82% | 7 |
|
|
2023
Q1 | $28.4M | Hold |
2,262,200
| – | – | 1.97% | 9 |
|
|
2022
Q4 | $33.2M | Hold |
2,262,200
| – | – | 3.82% | 10 |
|
|
2022
Q3 | $38.7M | Sell |
2,262,200
-50,168
| -2% | -$859K | 4.28% | 6 |
|
|
2022
Q2 | $33.8M | Sell |
2,312,368
-674,963
| -23% | -$9.85M | 3.39% | 7 |
|
|
2022
Q1 | $50.2M | Hold |
2,987,331
| – | – | 3.46% | 9 |
|
|
2021
Q4 | $67.2M | Hold |
2,987,331
| – | – | 4.05% | 6 |
|
|
2021
Q3 | $64.4M | Hold |
2,987,331
| – | – | 2.89% | 9 |
|
|
2021
Q2 | $86.6M | Sell |
2,987,331
-257,704
| -8% | -$7.47M | 3.75% | 8 |
|
|
2021
Q1 | $105M | Hold |
3,245,035
| – | – | 3.68% | 9 |
|
|
2020
Q4 | $134M | Buy |
+3,245,035
| New | +$134M | 5.99% | 4 |
|